Please assess the completion status of the following clinical trial:

Trial Title: Remote Ischemic Preconditioning in Patients Undergoing Isolated Aortic Valve Replacement Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Non-emergency aortic valve replacement with a biological prosthesis with perfusion and cardiac arrest~Exclusion Criteria:~* Recent myocardial infarction~* Carotid stenosis requiring intervention~* Any other concomitant surgical procedure~* Increased troponin baseline before surgery~* Critical ischemia of lower limbs~* Peripheral arterial disease (ASO, media sclerosis)~* Morbid obesity (Incompatible cuff-to-thigh diameter)~* Severe heart insufficiency~* Moderate to severe venous insufficiency lower limbs~* Recent acute stroke \<90d~* Difference in cardioplegic protocol~* Diseased aorta in epiaortic ultrasound

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Remote ischemic preconditioning (Type: EXPERIMENTAL): Patient will undergo normal isolated aortic valve replacement surgery with a biological prosthesis and a preoperative lower leg remote ischemic preconditioning(RIPC) phase.
- Control group (Type: NO_INTERVENTION): Patient will undergo normal isolated aortic valve replacement surgery with a biological prosthesis

Based on this trial design, predict the completion outcome and termination type (if applicable).